Current Clinical Trials
On August 13, 2009, the company received approval from Swissmedic to conduct a Phase II, dose escalation, clinical trial in Switzerland using Oxycyte in traumatic brain injury (TBI). It is a randomized, controlled, double-blind, dose escalation Phase II study to assess Safety and Tolerability. The company has named the study ““Safety and Tolerability of OXYCYTE in Patients with Traumatic Brain Injury” or “STOP TBI”.

The first patient was enrolled in December 2009. Since study participants will all be emergency cases, it is not possible to predict the precise timing of the flow of patients into the study.

For information on other clinical trials that are currently enrolling patients, please visit the following site: http://www.clinicaltrials.gov/